{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:12:34Z","timestamp":1791821554091,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Clinical and Translational Science","award":["1UL1TR001445"],"award-info":[{"award-number":["1UL1TR001445"]}]},{"DOI":"10.13039\/100006732","name":"New York University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.mayocp.2019.09.012","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T07:00:07Z","timestamp":1580713207000},"page":"384-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["Sex Differences in Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"95","author":[{"given":"Julie S.","family":"Nusbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Freilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J\u00a0Autoimmun"},{"issue":"10","key":"10.1016\/j.mayocp.2019.09.012_bib2","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/art.40192","article-title":"The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan Lupus Surveillance Program","volume":"69","author":"Izmirly","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2019.09.012_bib3","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/art.40191","article-title":"The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California Lupus Surveillance Project","volume":"69","author":"Dall'Era","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.22375","article-title":"Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort","volume":"56","author":"Andrade","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3899\/jrheum.111061","article-title":"Differences between male and female systemic lupus erythematosus in a multiethnic population","volume":"39","author":"Tan","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00005792-199605000-00002","article-title":"Systemic lupus erythematosus in males. A study of 107 Latin American patients","volume":"75","author":"Molina","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.genm.2011.10.003","article-title":"Sex differences in disease severity among patients with systemic lupus erythematosus","volume":"8","author":"Crosslin","year":"2011","journal-title":"Gend Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1191\/0961203305lu2245oa","article-title":"Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients","volume":"14","author":"Garcia","year":"2005","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.mayocp.2019.09.012_bib12","first-page":"1339","article-title":"Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus","volume":"49","author":"Mayor","year":"2003","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib13","first-page":"220","article-title":"Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations","volume":"17","author":"Ward","year":"1990","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/0961203316673728","article-title":"Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort","volume":"26","author":"Riveros Frutos","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/art.40392","article-title":"Sex differences in health care utilization, end-stage renal disease, and mortality among Medicaid beneficiaries with incident lupus nephritis","volume":"70","author":"Feldman","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mayocp.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12 to 26 years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-013-2266-7","article-title":"Human papillomavirus vaccine and systemic lupus erythematosus","volume":"32","author":"Gatto","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1016\/j.mayocp.2019.09.012_bib21","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12, pt 1","key":"10.1016\/j.mayocp.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.mayocp.2019.09.012_bib23","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A\u00a0trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"S\u00e1nchez-Guerrero","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.09.012_bib24","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/03009740902763099","article-title":"Reproductive health in women with systemic lupus erythematosus compared to population controls","volume":"38","author":"Ekblom-Kullberg","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C","article-title":"Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data","volume":"42","author":"Ramsey-Goldman","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"17","key":"10.1016\/j.mayocp.2019.09.012_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial. The Writing Group for the PEPI","volume":"276","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2019.09.012_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bone.2003.12.021","article-title":"Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study","volume":"34","author":"Bagger","year":"2004","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.mayocp.2019.09.012_bib30","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.012_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/acr.22791","article-title":"What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE","volume":"68","author":"Arkema","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/acr.23263","article-title":"Contribution of socioeconomic status to racial\/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus","volume":"70","author":"Kaplowitz","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.mayocp.2019.09.012_bib34","doi-asserted-by":"crossref","first-page":"e0182483","DOI":"10.1371\/journal.pone.0182483","article-title":"Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients","volume":"12","author":"Blazer","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.012_bib36","first-page":"1709","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/BOR.0000000000000415","article-title":"Pregnancy and reproductive aspects of systemic lupus erythematosus","volume":"29","author":"Andreoli","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib38","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","article-title":"Diagnostic evaluation of the infertile female: a committee opinion","volume":"103","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2015","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib39","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"103","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2015","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.012_bib40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-M\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib41","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.fertnstert.2010.01.016","article-title":"The time is now for a new approach to primary ovarian insufficiency","volume":"95","author":"Cooper","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mayocp.2019.09.012_bib42","first-page":"CD002922","article-title":"Treatment for lupus nephritis","volume":"12","author":"Henderson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"10.1016\/j.mayocp.2019.09.012_bib43","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","article-title":"The relationship of gonadal activity and chemotherapy-induced gonadal damage","volume":"259","author":"Rivkees","year":"1988","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)49537-3","article-title":"Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study","volume":"46","author":"Watson","year":"1986","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.012_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0961203312468624","article-title":"The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease","volume":"22","author":"Harward","year":"2013","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.09.012_bib47","first-page":"2571","article-title":"Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients","volume":"29","author":"Huong","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.012_bib48","first-page":"1152","article-title":"Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs","volume":"20","author":"Ramsey-Goldman","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.mayocp.2019.09.012_bib49","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10067-014-2686-z","article-title":"Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia","volume":"33","author":"Alarfaj","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.012_bib50","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/art.22660","article-title":"Gonad evaluation in male systemic lupus erythematosus","volume":"56","author":"Soares","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1450561","article-title":"Inhibin B in male reproduction: pathophysiology and clinical relevance","volume":"145","author":"Meachem","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.09.012_bib52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/rheumatology\/ken338","article-title":"Testicular Sertoli cell function in male systemic lupus erythematosus","volume":"47","author":"Suehiro","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2019.09.012_bib53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1191\/096120300680198926","article-title":"Profile of sex hormones in male patients with systemic lupus erythematosus","volume":"9","author":"Mok","year":"2000","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.mayocp.2019.09.012_bib54","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/art.23701","article-title":"Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome","volume":"58","author":"Scofield","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6507","key":"10.1016\/j.mayocp.2019.09.012_bib55","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.291.6507.1457","article-title":"Long term effects of cyclophosphamide on testicular function","volume":"291","author":"Watson","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.012_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-93-1-109","article-title":"Gonadal dysfunction in patients receiving chemotherapy for cancer","volume":"93","author":"Schilsky","year":"1980","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2019.09.012_bib57","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X","article-title":"Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas","volume":"70","author":"Meistrich","year":"1992","journal-title":"Cancer"},{"issue":"8231","key":"10.1016\/j.mayocp.2019.09.012_bib58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(81)92348-5","article-title":"Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods","volume":"1","author":"Trompeter","year":"1981","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.012_bib59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0961203312442753","article-title":"Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network","volume":"21","author":"Henes","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.012_bib61","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib62","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.39024","article-title":"Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus","volume":"67","author":"Brunner","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"issue":"17","key":"10.1016\/j.mayocp.2019.09.012_bib64","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"German Breast Group Investigators. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"29","author":"Gerber","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","article-title":"Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer","volume":"30","author":"Munster","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2011.991","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial","volume":"306","author":"Del Mastro","year":"2011","journal-title":"JAMA"},{"issue":"suppl 6","key":"10.1016\/j.mayocp.2019.09.012_bib67","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib68","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/pbc.21257","article-title":"Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives","volume":"50","author":"Ginsberg","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib69","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X\u00a0Chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"7031","key":"10.1016\/j.mayocp.2019.09.012_bib70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-Inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08916939709003851","article-title":"X-Chromosome inactivation in monozygotic twins with systemic lupus erythematosus","volume":"26","author":"Huang","year":"1997","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/ar118","article-title":"The role of X-chromosome inactivation in female predisposition to autoimmunity","volume":"2","author":"Chitnis","year":"2000","journal-title":"Arthritis Res"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2012-201851","article-title":"Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups","volume":"72","author":"Kaufman","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"29","key":"10.1016\/j.mayocp.2019.09.012_bib74","doi-asserted-by":"crossref","first-page":"e4272","DOI":"10.1097\/MD.0000000000004272","article-title":"Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"95","author":"Boodhoo","year":"2016","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib75","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1084\/jem.147.6.1568","article-title":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB\/NZW F1 mice","volume":"147","author":"Roubinian","year":"1978","journal-title":"J\u00a0Exp Med"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.09.012_bib76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2010.07.020","article-title":"Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice","volume":"229","author":"Gao","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib77","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/endo.135.6.7988450","article-title":"17 Beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL\/6J mice","volume":"135","author":"Verthelyi","year":"1994","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/jaut.1996.0121","article-title":"Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice","volume":"10","author":"Verthelyi","year":"1997","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib79","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI109390","article-title":"Delayed androgen treatment prolongs survival in murine lupus","volume":"63","author":"Roubinian","year":"1979","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2019.09.012_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib81","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-018-0712-y","article-title":"Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation","volume":"41","author":"Souyris","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.09.012_bib83","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.177.4.2088","article-title":"TLR7 ligands induce higher IFN-alpha production in females","volume":"177","author":"Bergh\u00f6fer","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.012_bib84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2014.01.006","article-title":"Estrogen modulation of endosome-associated Toll-like receptor 8: an IFN\u03b1-independent mechanism of sex-bias in systemic lupus erythematosus","volume":"151","author":"Young","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.mayocp.2019.09.012_bib85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2016.12.005","article-title":"Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus","volume":"176","author":"Young","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.mayocp.2019.09.012_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2055-2394-1-1","article-title":"Sex differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)","volume":"1","author":"Jiang","year":"2014","journal-title":"J\u00a0Immunother Appl"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.012_bib87","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in\u00a0vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib88","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gpb.2018.03.004","article-title":"Identification and analysis of human sex-biased microRNAs","volume":"16","author":"Cui","year":"2018","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.012_bib89","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI78082","article-title":"Sexual dimorphism in autoimmunity","volume":"125","author":"Rubtsova","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.mayocp.2019.09.012_bib90","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/bies.201100047","article-title":"X-Chromosome-located microRNAs in immunity: might they explain male\/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females","volume":"33","author":"Pinheiro","year":"2011","journal-title":"Bioessays"},{"issue":"12","key":"10.1016\/j.mayocp.2019.09.012_bib91","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2008-04-152488","article-title":"Suppression of LPS-induced interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation","volume":"112","author":"Dai","year":"2008","journal-title":"Blood"},{"issue":"38","key":"10.1016\/j.mayocp.2019.09.012_bib92","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/onc.2011.583","article-title":"Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer","volume":"31","author":"Paris","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.012_bib93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/138920209788185289","article-title":"Estrogen regulation of microRNA expression","volume":"10","author":"Klinge","year":"2009","journal-title":"Curr Genomics"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.012_bib94","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/zeb.2013.0873","article-title":"Estrogen regulation of microRNAs, target genes, and microRNA expression associated with\u00a0vitellogenesis in the zebrafish","volume":"11","author":"Cohen","year":"2014","journal-title":"Zebrafish"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.012_bib95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2042-6410-4-19","article-title":"Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB\/WF1 mice","volume":"4","author":"Dai","year":"2013","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.mayocp.2019.09.012_bib96","first-page":"151","article-title":"Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases","volume":"10","author":"Dai","year":"2014","journal-title":"Ther Clin Risk Manag"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:42Z","timestamp":1758418302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619308225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0025619619308225"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.09.012","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}